Your browser doesn't support javascript.
loading
Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
Ballard, Michael E; Mandelkern, Mark A; Monterosso, John R; Hsu, Eustace; Robertson, Chelsea L; Ishibashi, Kenji; Dean, Andy C; London, Edythe D.
Afiliación
  • Ballard ME; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles (Drs Ballard, Ishibashi, Dean, and London); Department of Molecular and Medical Pharmacology, University of California Los Angeles (Robertson and Dr London); Brain Research Institute, University of California L
  • Mandelkern MA; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles (Drs Ballard, Ishibashi, Dean, and London); Department of Molecular and Medical Pharmacology, University of California Los Angeles (Robertson and Dr London); Brain Research Institute, University of California L
  • Monterosso JR; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles (Drs Ballard, Ishibashi, Dean, and London); Department of Molecular and Medical Pharmacology, University of California Los Angeles (Robertson and Dr London); Brain Research Institute, University of California L
  • Hsu E; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles (Drs Ballard, Ishibashi, Dean, and London); Department of Molecular and Medical Pharmacology, University of California Los Angeles (Robertson and Dr London); Brain Research Institute, University of California L
  • Robertson CL; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles (Drs Ballard, Ishibashi, Dean, and London); Department of Molecular and Medical Pharmacology, University of California Los Angeles (Robertson and Dr London); Brain Research Institute, University of California L
  • Ishibashi K; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles (Drs Ballard, Ishibashi, Dean, and London); Department of Molecular and Medical Pharmacology, University of California Los Angeles (Robertson and Dr London); Brain Research Institute, University of California L
  • Dean AC; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles (Drs Ballard, Ishibashi, Dean, and London); Department of Molecular and Medical Pharmacology, University of California Los Angeles (Robertson and Dr London); Brain Research Institute, University of California L
  • London ED; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles (Drs Ballard, Ishibashi, Dean, and London); Department of Molecular and Medical Pharmacology, University of California Los Angeles (Robertson and Dr London); Brain Research Institute, University of California L
Int J Neuropsychopharmacol ; 18(7): pyu119, 2015 Jan 20.
Article en En | MEDLINE | ID: mdl-25603861

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Recompensa / Receptores de Dopamina D2 / Trastornos Relacionados con Anfetaminas / Cuerpo Estriado / Tomografía de Emisión de Positrones / Receptores de Dopamina D3 / Metanfetamina Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Neuropsychopharmacol Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Recompensa / Receptores de Dopamina D2 / Trastornos Relacionados con Anfetaminas / Cuerpo Estriado / Tomografía de Emisión de Positrones / Receptores de Dopamina D3 / Metanfetamina Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Neuropsychopharmacol Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2015 Tipo del documento: Article